Trials / Recruiting
RecruitingNCT06580418
Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Inotrem · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
TIME is an observational study performed on UC and CD patients under endoscopic surveillance for monitoring the clinical activity of their disease. The main objective of the study is to confirm the therapeutic potential of TREM-1 in inflammatory bowel disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Additional biopsies and blood samples | During the endoscopic procedure planned for IBD patients following standard clinical practice, the endoscopist will decide the number and location of additional biopsy samples (up to 8) collected for the study. Participation in this study also requires the removal of three additional blood samples. |
Timeline
- Start date
- 2023-01-31
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
- First posted
- 2024-08-30
- Last updated
- 2025-02-27
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06580418. Inclusion in this directory is not an endorsement.